SAN FRANCISCO—Back in November, news of a cardiovascular outcomes win for Trulicity ... form—is also part of the group, and it showed in 2016 that it could cut cardiovascular problems by 26% ...

(Reuters) - Eli Lilly and Co said on Monday that its top-selling diabetes drug Trulicity significantly reduced the risk of heart attack, stroke and heart-related death in a broad range of people ...

Lilly began its HCP marketing push for Trulicity last year, first targeting endocrinologists in November and then primary care providers in February. The drugmaker spent $5.49 million on professional ...

INDIANAPOLIS, June 26, 2019 /PRNewswire/ -- Eli Lilly and Company's (NYSE: LLY) trial studying higher investigational doses of Trulicity ... leader in diabetes care since 1923, when we introduced ...

Eli Lilly's top-launching new meds Trulicity and Taltz didn't deliver as expected in the first quarter, and executives faced a grilling Tuesday on what they plan to do about it. Market-watchers ...

Eli Lilly’s diabetes drugs Mounjaro and Trulicity are in short supply due to heightened demand for the medication, the Food and Drug Administration (FDA) announced recently. Pharmacies are ...